Idenix Pharmaceuticals to Present at the Canaccord Adams' Hepatitis C Conference
Poster: SySAdmin
Posted on March 26, 2010 at 7:14:01 AM
Idenix Pharmaceuticals to Present at the Canaccord Adams' Hepatitis C Conference
CAMBRIDGE, Mass., March 26 -- Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX) announced today that management will present a corporate overview at the upcoming Canaccord Adams' Hepatitis C Conference on Thursday, April 1, 2010 at 10:45 a.m. ET at The Peninsula Hotel, New York.
The live and archived webcast of the company presentation can be accessed under "Calendar of Events" in the Idenix Investor Center at http://www.idenix.com. Please log in approximately 5-10 minutes before the event to ensure a timely connection. The archived replay will be available on the Idenix website for two weeks following the conference.
About Idenix
Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases. Idenix's current focus is on the treatment of infections caused by the hepatitis C virus. For further information about Idenix, please refer to http://www.idenix.com/.
Idenix Pharmaceuticals Contact:
Teri Dahlman (617) 995-9905
Source: Idenix Pharmaceuticals, Inc.
CONTACT: Teri Dahlman, Idenix Pharmaceuticals, +1-617-995-9905
Web Site: http://www.idenix.com/
CAMBRIDGE, Mass., March 26 -- Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX) announced today that management will present a corporate overview at the upcoming Canaccord Adams' Hepatitis C Conference on Thursday, April 1, 2010 at 10:45 a.m. ET at The Peninsula Hotel, New York.
The live and archived webcast of the company presentation can be accessed under "Calendar of Events" in the Idenix Investor Center at http://www.idenix.com. Please log in approximately 5-10 minutes before the event to ensure a timely connection. The archived replay will be available on the Idenix website for two weeks following the conference.
About Idenix
Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases. Idenix's current focus is on the treatment of infections caused by the hepatitis C virus. For further information about Idenix, please refer to http://www.idenix.com/.
Idenix Pharmaceuticals Contact:
Teri Dahlman (617) 995-9905
Source: Idenix Pharmaceuticals, Inc.
CONTACT: Teri Dahlman, Idenix Pharmaceuticals, +1-617-995-9905
Web Site: http://www.idenix.com/